New York, NY (PRWEB) July 22, 2015
Spheryx, Inc. announced today that their technology for Total Holographic Characterization has been selected by an independent judging panel and the editors of R&D Magazine as a finalist for a 2015 R&D 100 Award in the Analytical/Test category.
R&D 100 Awards recognize the 100 most technologically significant products introduced in the past year. Selection is based on products’ design, development, testing and production of products and on the impact they are having in their fields.
The winners of the 2015 R&D 100 Awards will be announced at the R&D 100 annual gala banquet to be held on Friday, November 13 at Caesars Palace in Las Vegas, Nevada, as part of the 2015 R&D 100 Technology Conference.
Previous winners in the consumer products arena include: the fax machine (1975), halogen lamps (1974), and HDTV (1998). More recent breakthroughs that have earned R&D 100 Awards include next-generation magnetic resonance imaging machines, laser-based metal-forming tools, and the building blocks for fusion experiments.
Dr. Laura Philips, President and CEO of Spheryx commented, “It is an honor to have Total Holographic Characterization selected as a finalist for the R&D 100 award, especially considering the caliber of products that have previously received this award.”
About Spheryx, Inc.
Spheryx, Inc. is a privately held analytical services and instruments company providing Total Holographic CharacterizationTM of colloidal materials. Spheryx’s breakthrough proprietary technology uses holographic video microscopy to characterize each particle in colloidal dispersions and multi-component colloidal mixtures, thereby offering unprecedented insights into these materials’ characteristics. Applications include research and development, quality assurance and manufacturing process control across a broad spectrum of industries, where characterization of colloids can enhance innovation, improve safety and reduce costs. For more information please visit the company’s website at http://www.spheryx.solutions/
Note: This news release contains forward-looking statements regarding future events. These statements are just predictions and are subject to risks and uncertainties that could cause the actual events or result to differ materially. These risks and uncertainties include, among others: the results, timing and costs of our studies; our ability to obtain future funding on acceptable terms; the possible impairment of, or inability to obtain intellectual property rights; and innovation by our competitors.